What amount sold does GIODIA Ltd report in Form D filings?

The latest linked filings report $0 sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was GIODIA Ltd's most recent SEC filing?

GIODIA Ltd's most recent Form D filing was on 2022-01-21.

What type of securities does GIODIA Ltd offer?

GIODIA Ltd's SEC Form D filings indicate debt offerings.

GIODIA Ltd

CIK: 0001905766·Biotechnology·LONDON, X0·Corporation·Founded 2021

Reported Sold

Total Filings

Identified Offerings

Last Filed

Jan 21, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jan 21, 2022Form D — New notice

Reported sold: $0 · Target: $24,500,000

Rule 506(c)·0 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

$2,000,000

Amendment Rate

Latest reported sold across 1 identified offering

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Amal Sharma

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 21, 2022	New	$24,500,000	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Pictura Bio US, Inc.

Biotechnology

Offering target: $17,460,598

Filed Sep 25, 2026